NCT01649687View on ClinicalTrials.gov

Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Cerebellar Ataxia
Interventions
BIOLOGICAL

Allogeneic adult adipose-derived mesenchymal stem cells

Patients will receive intravenously one dose of 5-7x10\^7 cells of allogeneic adipose-derived mesenchymal stem cells

Trial Locations (1)

Unknown

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

National Yang Ming Chiao Tung University

OTHER

NCT01649687 - Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells | Biotech Hunter | Biotech Hunter